Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 10:10 PM
Study NCT ID:
NCT00701558
Status:
COMPLETED
Last Update Posted:
2016-06-24
First Post:
2008-06-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Unresectable Advanced and/or Metastatic Non-Small Cell Lung Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-08
Start Date Type:
None
Primary Completion Date:
2010-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-12
Completion Date Type:
ACTUAL
First Submit Date:
2008-06-18
First Submit QC Date:
None
Study First Post Date:
2008-06-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-04-14
Results First Submit QC Date:
None
Results First Post Date:
2016-05-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-05-24
Last Update Post Date:
2016-06-24
Last Update Post Date Type:
ESTIMATED